Preferences of lung cancer patients for treatment and decision-making: a systematic literature review-Reference-Cited by-同舟云学术

Preferences of lung cancer patients for treatment and decision-making: a systematic literature review

Published:2015-12-17 Issue:4 Volume:25 Page:580-591
ISSN:0961-5423
Container-title:European Journal of Cancer Care
language:en
Short-container-title:Eur J Cancer Care

Author:

Schmidt K.¹,Damm K.¹²,Prenzler A.¹²,Golpon H.²³,Welte T.²³

Affiliation:

1. Leibniz University Hannover; Center for Health Economics Research Hannover (CHERH); Hannover Germany

2. Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH); Member of the German Center for Lung Research (DZL); Hannover Germany

3. Hannover Medical School; Clinic for Pneumology; Hannover Germany

Funder

Bundesministerium für Bildung und Forschung

Publisher

Wiley

Subject

Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ecc.12425/fullpdf

Reference42 articles.

1. Perception of alopecia by patients requiring chemotherapy for non-small-cell lung cancer: a willingness to pay study;Bernard;Lung Cancer,2011

2. Patients' preferences for chemotherapy in non-small-cell lung cancer: a systematic review;Blinman;Lung Cancer,2010

3. Lung cancer clinicians' preferences for adjuvant chemotherapy in non-small-cell lung cancer: what makes it worthwhile?;Blinman;Lung Cancer,2011

4. Patients' preferences for treatment outcomes for advanced non-small cell lung cancer: a conjoint analysis;Bridges;Lung Cancer,2012

5. A treatment trade-off based decision aid for patients with locally advanced non-small cell lung cancer;Brundage;Health Expectations,2000

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patients' Preferences for Adjuvant Osimertinib in Non-Small-Cell Lung Cancer After Complete Surgical Resection: What Makes It Worth It to Patients?;CLIN LUNG CANCER;2024

2. Patients' Preferences for Adjuvant Osimertinib in Non–Small-Cell Lung Cancer After Complete Surgical Resection: What Makes It Worth It to Patients?;Clinical Lung Cancer;2024-09

3. The impact of decision tools during oncological consultation with lung cancer patients: A systematic review within the I3LUNG project;Cancer Medicine;2024-05

4. Is it too early to recommend local treatment in oligometastatic non-small cell lung cancer: a plea for equipoise;British Journal of Radiology;2024-03-27

5. A Longitudinal Evaluation of the Preferences of Patients With Advanced Cancer for Quality of Life and Survival in Malaysia: A Discrete Choice Experiment;Value in Health;2023-12